Free Trial
OTCMKTS:VYCO

Vycor Medical (VYCO) Stock Price, News & Analysis

$0.07 0.00 (-0.30%)
As of 10/9/2026

About Vycor Medical Stock (OTCMKTS:VYCO)

Advanced

Key Stats

Today's Range
$0.07
▼
$0.07
50-Day Range
$0.05
▼
$0.07
52-Week Range
$0.03
▼
$0.20
Volume
N/A
Average Volume
0 shs
Market Capitalization
$2.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vycor Medical, Inc. is a medical-device company focused on developing products for neurosurgical procedures. Its primary product is the ViewSite Brain Access System, a transparent tubular retractor designed to provide surgeons with access to intracranial surgical sites while helping preserve visibility of surrounding tissue.

The ViewSite system is intended for use in minimally invasive neurosurgery and may support procedures involving the removal of tumors, blood clots and other abnormalities. The company has also developed related visualization and access technologies, including products designed to work with neuroendoscopic equipment.

Vycor Medical markets its products to hospitals, neurosurgeons and other healthcare providers. Publicly available information about the company’s current leadership, geographic operations and broader product portfolio is limited.

AI Generated. May Contain Errors.

Receive VYCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vycor Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VYCO Stock News Headlines

The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
VYCO Vycor Medical, Inc.
See More Headlines

VYCO Stock Analysis - Frequently Asked Questions

Vycor Medical's stock was trading at $0.1210 at the start of the year. Since then, VYCO stock has decreased by 44.6% and is now trading at $0.0670.

Vycor Medical, Inc. (OTCMKTS:VYCO) released its earnings results on Thursday, May, 15th. The medical device company reported ($0.01) EPS for the quarter. The medical device company had revenue of $0.44 million for the quarter.

Shares of VYCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vycor Medical investors own include ACADIA Pharmaceuticals (ACAD), Canopy Growth (CGC), CorMedix (CRMD) and Drone Aviation (DRNE).

Company Calendar

Last Earnings
5/15/2025
Today
10/10/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:VYCO
Previous Symbol
OTCMKTS:VYCO
CIK
1424768
Employees
6
Year Founded
2005

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$70 thousand
Net Margins
-3.30%
Pretax Margin
-3.12%
Return on Equity
N/A
Return on Assets
-4.70%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.13
Quick Ratio
0.09

Sales & Book Value

Annual Sales
$1.86 million
Price / Sales
1.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.12) per share
Price / Book
-0.56

Miscellaneous

Outstanding Shares
33,420,000
Free Float
31,074,000
Market Cap
$2.24 million
Optionable
Not Optionable
Beta
-0.54

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (OTCMKTS:VYCO) was last updated on 10/10/2026 by MarketBeat.com Staff.
From Our Partners